Control group:Perform normal treatment without probiotic intervention.

2 trials

Sponsors

School of Medicine, Wuhan University of Science and Technology

Conditions

Acute upper respiratory tract infectionOral mucositis

Early Phase 1

Clinical efficacy and mechanism of oropharyngeal probiotic DSM 34540 in the adjuvant treatment of acute upper respiratory tract infections and prevention of secondary bacterial infections in children

RecruitingChiCTR2300071252

School of Medicine, Wuhan University of Science and TechnologyAcute upper respiratory tract infection

Start: 2023-06-01Updated: 2023-06-12

Study on the efficacy of oropharyngeal probiotic DSM 34540 in relieving oral mucositis in patients with nasopharyngeal carcinoma undergoing simultaneous radiotherapy

Active, not recruitingChiCTR2500096223

School of Medicine, Wuhan University of Science and TechnologyOral mucositis

Start: 2020-06-09Updated: 2025-01-27